Long Term Debt Summary of KPC Pharmaceuticals, Inc.

KPC Pharmaceuticals, Inc.'s latest annual long term debt in 2023 was 107.56 Million CNY , up 2.67% from previous year.
KPC Pharmaceuticals, Inc.'s latest quarterly long term debt in 2024 Q1 was 97.05 Million CNY , down -9.77% from previous quarter.
KPC Pharmaceuticals, Inc. reported annual long term debt of 104.76 Million CNY in 2022, down -30.14% from previous year.
KPC Pharmaceuticals, Inc. reported annual long term debt of 149.97 Million CNY in 2021, up 50.43% from previous year.
KPC Pharmaceuticals, Inc. reported quarterly long term debt of 56.53 Million CNY for 2024 Q3, down -55.5% from previous quarter.
KPC Pharmaceuticals, Inc. reported quarterly long term debt of 97.05 Million CNY for 2024 Q1, down -9.77% from previous quarter.

Annual Long Term Debt Chart of KPC Pharmaceuticals, Inc. (2023 - 1997)

Historical Annual Long Term Debt of KPC Pharmaceuticals, Inc. (2023 - 1997)

Year	Long Term Debt	Long Term Debt Growth
2023	107.56 Million CNY	2.67%
2022	104.76 Million CNY	-30.14%
2021	149.97 Million CNY	50.43%
2020	99.7 Million CNY	49.48%
2019	66.7 Million CNY	-73.8%
2018	254.6 Million CNY	-24.93%
2017	339.12 Million CNY	13.7%
2016	298.27 Million CNY	0.15%
2015	297.83 Million CNY	29783374500.0%
2014	1.00 CNY	0.0%
2013	- CNY	-100.0%
2012	21.9 Million CNY	119.0%
2011	10 Million CNY	-50.0%
2010	20 Million CNY	-41.18%
2009	34 Million CNY	142.86%
2008	14 Million CNY	2700.0%
2007	500 Thousand CNY	-99.12%
2006	56.63 Million CNY	-16.27%
2005	67.64 Million CNY	6664.0%
2004	1 Million CNY	0.0%
2003	1 Million CNY	0.0%
2002	1 Million CNY	-92.31%
2001	12.99 Million CNY	164.78%
2000	4.9 Million CNY	0.0%
1999	- CNY	0.0%
1998	- CNY	-100.0%
1997	17.7 Million CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	127.04 Million CNY	30.9%
2024 Q3	56.53 Million CNY	-55.5%
2024 Q1	97.05 Million CNY	-9.77%
2023 Q1	106.69 Million CNY	1.84%
2023 Q3	145.79 Million CNY	121.53%
2023 Q2	65.81 Million CNY	-38.32%
2023 Q4	107.56 Million CNY	-26.22%
2023 FY	107.56 Million CNY	2.67%
2022 FY	104.76 Million CNY	-30.14%
2022 Q2	126.32 Million CNY	-39.31%
2022 Q1	208.15 Million CNY	38.79%
2022 Q3	122.72 Million CNY	-2.86%
2022 Q4	104.76 Million CNY	-14.63%
2021 Q4	149.97 Million CNY	19.28%
2021 FY	149.97 Million CNY	50.43%
2021 Q1	133.14 Million CNY	33.54%
2021 Q2	125.98 Million CNY	-5.37%
2021 Q3	125.73 Million CNY	-0.2%
2020 Q3	100 Million CNY	0.2%
2020 Q1	66.7 Million CNY	0.0%
2020 FY	99.7 Million CNY	49.48%
2020 Q2	99.8 Million CNY	49.63%
2020 Q4	99.7 Million CNY	-0.3%
2019 Q2	105.2 Million CNY	-58.68%
2019 FY	66.7 Million CNY	-73.8%
2019 Q4	66.7 Million CNY	-42.0%
2019 Q1	254.6 Million CNY	0.0%
2019 Q3	115 Million CNY	9.32%
2018 Q3	250.3 Million CNY	-54.44%
2018 Q2	549.36 Million CNY	17.07%
2018 Q1	469.24 Million CNY	38.37%
2018 FY	254.6 Million CNY	-24.93%
2018 Q4	254.6 Million CNY	1.72%
2017 Q3	339.12 Million CNY	13.61%
2017 FY	339.12 Million CNY	13.7%
2017 Q4	339.12 Million CNY	0.0%
2017 Q2	298.5 Million CNY	0.04%
2017 Q1	298.38 Million CNY	0.04%
2016 Q2	298.06 Million CNY	0.04%
2016 Q3	298.18 Million CNY	0.04%
2016 FY	298.27 Million CNY	0.15%
2016 Q4	298.27 Million CNY	0.03%
2016 Q1	297.95 Million CNY	0.04%
2015 FY	297.83 Million CNY	29783374500.0%
2015 Q2	1.00 CNY	0.0%
2015 Q3	299.86 Million CNY	29986833200.0%
2015 Q4	297.83 Million CNY	-0.68%
2015 Q1	1.00 CNY	0.0%
2014 FY	- CNY	0.0%
2014 Q2	25 Million CNY	0.0%
2014 Q4	1.00 CNY	-100.0%
2014 Q3	24.5 Million CNY	-2.0%
2014 Q1	25 Million CNY	0.0%
2013 FY	- CNY	-100.0%
2013 Q1	21.9 Million CNY	0.0%
2013 Q2	21.9 Million CNY	0.0%
2013 Q3	- CNY	-100.0%
2013 Q4	- CNY	0.0%
2012 Q1	10 Million CNY	0.0%
2012 FY	21.9 Million CNY	119.0%
2012 Q3	10 Million CNY	0.0%
2012 Q2	10 Million CNY	0.0%
2012 Q4	21.9 Million CNY	119.0%
2011 Q4	10 Million CNY	0.0%
2011 FY	10 Million CNY	-50.0%
2011 Q2	- CNY	-100.0%
2011 Q3	10 Million CNY	0.0%
2011 Q1	20 Million CNY	0.0%
2010 Q4	20 Million CNY	-41.18%
2010 Q1	34 Million CNY	0.0%
2010 FY	20 Million CNY	-41.18%
2010 Q3	34 Million CNY	0.0%
2010 Q2	34 Million CNY	0.0%
2009 Q2	34 Million CNY	142.86%
2009 Q1	14 Million CNY	0.0%
2009 Q3	34 Million CNY	0.0%
2009 Q4	34 Million CNY	0.0%
2009 FY	34 Million CNY	142.86%
2008 Q2	- CNY	-100.0%
2008 FY	14 Million CNY	2700.0%
2008 Q4	14 Million CNY	-58.82%
2008 Q3	34 Million CNY	0.0%
2008 Q1	500 Thousand CNY	0.0%
2007 Q3	50.1 Million CNY	-16.64%
2007 FY	500 Thousand CNY	-99.12%
2007 Q1	60.13 Million CNY	6.18%
2007 Q2	60.1 Million CNY	-0.06%
2007 Q4	500 Thousand CNY	-99.0%
2006 Q4	56.63 Million CNY	-16.22%
2006 Q3	67.6 Million CNY	0.0%
2006 FY	56.63 Million CNY	-16.27%
2006 Q2	67.6 Million CNY	-0.06%
2006 Q1	67.64 Million CNY	0.0%
2005 Q4	67.64 Million CNY	0.06%
2005 Q2	12.6 Million CNY	1160.0%
2005 Q1	1 Million CNY	0.0%
2005 FY	67.64 Million CNY	6664.0%
2005 Q3	67.6 Million CNY	436.51%
2004 Q2	1 Million CNY	0.0%
2004 Q4	1 Million CNY	0.0%
2004 Q3	1 Million CNY	0.0%
2004 Q1	1 Million CNY	0.0%
2004 FY	1 Million CNY	0.0%
2003 Q2	17.8 Million CNY	1651.11%
2003 Q3	6 Million CNY	-66.29%
2003 Q4	1 Million CNY	-83.33%
2003 Q1	1.01 Million CNY	1.65%
2003 FY	1 Million CNY	0.0%
2002 Q1	12.99 Million CNY	0.0%
2002 FY	1 Million CNY	-92.31%
2002 Q4	1 Million CNY	-90.92%
2002 Q3	11.01 Million CNY	0.0%
2002 Q2	11.01 Million CNY	-15.23%
2001 Q4	12.99 Million CNY	0.0%
2001 FY	12.99 Million CNY	164.78%
2001 Q2	1 Million CNY	0.0%
2000 FY	4.9 Million CNY	0.0%
1999 FY	- CNY	0.0%
1998 FY	- CNY	-100.0%
1997 FY	17.7 Million CNY	0.0%

Peer Long Term Debt Comparison of KPC Pharmaceuticals, Inc.

Name	Long Term Debt	Long Term Debt Difference
Shanghai Haoyuan Chemexpress Co., Ltd.	229.23 Million CNY	53.077%
Hubei Jumpcan Pharmaceutical Co., Ltd.	1.43 Million CNY	-7398.606%
Yabao Pharmaceutical Group Co., Ltd	3.36 Million CNY	-3092.51%
Shandong Lukang Pharmaceutical Co.,Ltd.	1.3 Billion CNY	91.782%
Zhejiang Huahai Pharmaceutical Co., Ltd.	4.02 Billion CNY	97.326%
Tasly Pharmaceutical Group Co., Ltd	1.41 Billion CNY	92.388%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited	241.03 Million CNY	55.375%
Lionco Pharmaceutical Group Co.,Ltd.	445.18 Million CNY	75.839%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.	70.75 Million CNY	-52.026%
China Animal Husbandry Industry Co., Ltd.	899.03 Million CNY	88.036%
Jiangsu Kanion Pharmaceutical Co.,Ltd.	1.92 Million CNY	-5486.177%
Zhejiang Shengda Bio-Pharm Co., Ltd.	144 Million CNY	25.305%
Tianjin Tianyao Pharmaceuticals Co., Ltd.	277 Million CNY	61.169%
Henan Lingrui Pharmaceutical Co., Ltd.	6.96 Million CNY	-1444.954%
Guizhou Yibai Pharmaceutical Co., Ltd.	387.22 Million CNY	72.223%
Zhongzhu Healthcare Holding Co.,Ltd	12.76 Million CNY	-742.651%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.	10.95 Million CNY	-882.051%
Jianmin Pharmaceutical Group Co.,Ltd.	30.29 Million CNY	-255.055%
North China Pharmaceutical Company Ltd.	4.08 Billion CNY	97.364%
CanSino Biologics Inc.	1.07 Billion CNY	89.986%
Zhejiang Hisun Pharmaceutical Co., Ltd.	2.39 Billion CNY	95.514%
Heilongjiang ZBD Pharmaceutical Co., Ltd.	1.29 Billion CNY	91.714%
ChengDu ShengNuo Biotec Co.,Ltd.	189.19 Million CNY	43.148%
Dali Pharmaceuticalco.,Ltd	14.84 Million CNY	-624.344%
Harbin Pharmaceutical Group Co., Ltd.	32.62 Million CNY	-229.65%
Zhejiang Medicine Co., Ltd.	230.54 Million CNY	53.345%
HPGC Renmintongtai Pharmaceutical Corporation	29.4 Million CNY	-265.744%
Humanwell Healthcare (Group) Co.,Ltd.	1.65 Billion CNY	93.483%
Ginwa Enterprise (Group) Inc.	5.42 Million CNY	-1881.099%
Changchun BCHT Biotechnology Co.	-9.85 Million CNY	1191.301%
Jiangsu Jibeier Pharmaceutical Co., Ltd.	- CNY	-Infinity%
Ningbo Menovo Pharmaceutical Co., Ltd.	759.64 Million CNY	85.841%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd	389.05 Million CNY	72.353%
Nanjing Well Pharmaceutical Group Co.,Ltd.	104.06 Million CNY	-3.36%
Joincare Pharmaceutical Group Industry Co.,Ltd.	3.12 Billion CNY	96.555%
China Resources Double-Crane Pharmaceutical Co.,Ltd.	29.94 Million CNY	-259.141%
Chongqing Taiji Industry(Group) Co.,Ltd	341.6 Million CNY	68.513%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited	3.32 Billion CNY	96.764%
China National Medicines Corporation Ltd.	205.07 Million CNY	47.55%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.	316.84 Million CNY	66.053%
Shenzhen Chipscreen Biosciences Co., Ltd.	1.02 Billion CNY	89.485%
Beijing Tongrentang Co., Ltd	1.42 Billion CNY	92.477%
Tibet Weixinkang Medicine Co., Ltd.	3.81 Million CNY	-2716.607%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	13.5 Billion CNY	99.204%
Hunan Fangsheng Pharmaceutical Co., Ltd.	174 Million CNY	38.185%
Guangxi Wuzhou Zhongheng Group Co.,Ltd	553.47 Million CNY	80.566%
Shanghai Jiaoda Onlly Co.,Ltd	120.22 Million CNY	10.536%
Jiang Zhong Pharmaceutical Co.,Ltd	1.04 Million CNY	-10166.439%
Guobang Pharma Ltd.	451.7 Million CNY	76.187%
Mayinglong Pharmaceutical Group Co., LTD.	128.45 Million CNY	16.268%
Cisen Pharmaceutical Co., Ltd.	132.53 Million CNY	18.841%
Hunan Warrant Pharmaceutical Co.,Ltd	17.1 Million CNY	-528.779%
Shaanxi Kanghui Pharmaceutical Co., Ltd.	283.87 Million CNY	62.11%
Shandong Buchang Pharmaceuticals Co., Ltd.	2.09 Billion CNY	94.873%
Zhejiang Starry Pharmaceutical Co.,Ltd.	734.44 Million CNY	85.355%
Kangmei Pharmaceutical Co., Ltd.	188.16 Million CNY	42.836%
Henan Taloph Pharmaceutical Stock Co.,Ltd	183.8 Million CNY	41.479%
ZhuZhou QianJin Pharmaceutical Co.,Ltd	38.46 Million CNY	-179.65%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd	512.37 Million CNY	79.007%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.	40.62 Million CNY	-164.781%
Shanghai Shyndec Pharmaceutical Co., Ltd.	1.03 Billion CNY	89.567%
Shanghai Yizhong Pharmaceutical Co., Ltd.	- CNY	-Infinity%
Tibet Rhodiola Pharmaceutical Holding Co.	1.12 Million CNY	-9457.366%
Sichuan Huiyu Pharmaceutical Co., Ltd.	2.04 Million CNY	-5151.221%
Jiangsu Lianhuan Pharmaceutical Co., Ltd.	82.91 Million CNY	-29.729%

Global Stocks Search

KPC Pharmaceuticals, Inc. (600422.SS)

Long Term Debt Summary of KPC Pharmaceuticals, Inc.

Annual Long Term Debt Chart of KPC Pharmaceuticals, Inc. (2023 - 1997)

Historical Annual Long Term Debt of KPC Pharmaceuticals, Inc. (2023 - 1997)

Peer Long Term Debt Comparison of KPC Pharmaceuticals, Inc.